Diagnostic values of surface-enhanced laser desorption/ionization technology for screening of habitual drinkers

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue SUPPL. 1, 2007, Pages

  Sogawa, Kazuyuki ^a   Itoga, Sakae ^a   Tomonaga, Takeshi ^a   Nomura, Fumio ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Alcohol; CDT; Fibrinogen; GGT; Proteome

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; BLOOD SAMPLING; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; ALCOHOLISM; APOLIPOPROTEINS A; BIOLOGICAL MARKERS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFERRIN;

EID: 33846305075     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2006.00282.x     Document Type: Conference Paper

References (21)

1. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62:3609-3614.
2. Anton RF, Lieber C, Tobakoff B (2002) Carbohydrate-deficient transferrin and [gamma]-Glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215-1222.
3. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT and AST as markers of alcohol & experimental research. Alcohol Clin Exp Res 26:332-339.
4. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 41:489-537.
5. Edlue MT, Crystal GW, Dwana AY, Hernan EG, Francois MB (2002) Alcohol-induced up-regulation of fibrinolytic activity and plasminogen activators in human monocytes. Alcohol Clin Exp Res 26:1121-1127.
6. El-Sayed MS, Nieuwenhuizen W (2000) The effect of alcohol ingestion on the exercise-induced in fibrin and fibrinogen degradation products in man. Blood Coagul Fibrin 11:359-365.
7. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36.
8. Kenneth JM, Praveen PJ, Ralph BD, Joseph MM, Murray AM, Izabella L, Patrice AS, Travis M, Danial L, Peter WF, Ellison RC, Halit S, James EM, Geoffrey HT (2001) Alcohol consumption and hemostatic factors analysis of the Framingham offspring cohort. Circulation 104:1367-1373.
9. Lakshman R, Tsutsumi M, Ghosh P, Takase S, Anni H, Nikolaeva O, Israel Y, Anton RF, Lesch OM, Helender A, Eriksson G, Jeppson JO, Marmillot P, Rao MN (2001) Alcohol biomarkers: clinical significance and biochemical basis. Alcohol Clin Exp Res 25 (suppl): 67-70.
10. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296-1304.
11. Lieber CS (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32 (suppl): 113-128.
12. Nomura F, Tomonaga T, Sogawa K, Ohashi T, Nezu M, Sunaga M, Kondo N, Iyo M, Shimada H, Ochiai T (2004) Identification of novel and downregulated biomarkers for alcoholism by surface enhanced qlaser desorption/ionization-mass spectrometry. Proteomics 4:1187-1194.
13. Orrego H, Blake JE, Blendis LM, Kapur BM, Israel Y (1979) Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 22:1354-1356.
14. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002a) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577.
15. Petricoin EF III, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA (2002b) Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94:1576-1578.
16. Qu Y, Adam BL, Yasui Y (2002) Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profile discriminates prostate cancer from noncancer patients. Clin Chem 48:1835-1843.
17. Robinson MK, Myrick JE, Henderson LO, Coles CD, Powell MK, Orr GA, Lemkin PF (1995) Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome. Electrophoresis 16:1176-1183.
18. Rosman AS, Lieber CS (1994) Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 40:1641-1651.
19. Sidney BR, Donald R (1972) Serum γ-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39:41-47.
20. Stibler H (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037.
21. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation toll in clinical medicine. Clin Chem 39:561-577.